Filing Details

Accession Number:
0001144204-13-015636
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-18 11:10:19
Reporting Period:
2013-03-15
Filing Date:
2013-03-18
Accepted Time:
2013-03-18 11:10:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
810509 Navidea Biopharmaceuticals Inc. NAVB In Vitro & In Vivo Diagnostic Substances (2835) 311080091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1528192 H. Thomas Tulip 425 Metro Place North
Suite 450
Dublin OH 43017
Evp & Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-03-15 17,500 $2.82 45,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 940 Indirect By 401(k)
Footnotes
  1. Price represents a weighted average of the purchase price. Shares were purchased at prices ranging from $2.81 - $2.89. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares purchased at each separate price.